5 November 2023
RNZ's Kim Hill discusses the results of the Malaghan Institute's phase 1 clinical trial.
Michele Leggott / Dr Robert Weinkove / Prof Carl June
Results have been released for Malaghan Institute's ground-breaking CAR T-cell cancer therapy trial, and they are promising.
The therapy reprogrammes a patient's own immune cells to recognise and kill cancer.
Discussing the treatment and trial are Professor Carl June from the University of Pennsylvania who pioneered the therapy and Dr Robert Weinkove, who leads Malaghan's CAR T-cell programme.
They are joined by writer and poet Michele Leggott, who is twelve months into the trial, for an update on her progress.
Related articles
Kjesten Wiig: bringing life-changing treatments to life
27 February 2025
Read more
Kjesten Wiig: bringing life-changing treatments to life
27 February 2025
Read more
Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
24 February 2025
Read more
Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
24 February 2025
Read more
Cancer Research Trust grant to improve CAR T-cell therapy
12 February 2025
Read more
Cancer Research Trust grant to improve CAR T-cell therapy
12 February 2025
Read more